Quinolinic acid accumulation in injured spinal cord: Time course, distribution, and species differences between rat and guinea pig

Journal of Neurotrauma

Volumn 14, Issue 2, 1997, Pages 89-98

  Blight, Andrew R ^a   Leroy Jr , E Carwile ^a   Heyes, Melvyn P ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

inflammation; macrophage; quinolinate; somatosensory evoked potentials; spinal trauma

Indexed keywords

QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EVOKED SOMATOSENSORY RESPONSE; GUINEA PIG; MACROPHAGE FUNCTION; NEUROPATHOLOGY; NONHUMAN; SPECIES DIFFERENTIATION; SPINAL CORD INJURY;

EID: 0030995974     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.89     Document Type: Article

References (41)

1. ANDERSON, D.K., BRAUGHLER, J.M., HALL, E.D., WATERS, T.R., MCCALL, J.M., and MEANS, E.D. (1988a). Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J. Neurosurg. 69, 562-567.
2. ANDERSON, D.K., WATERS, T.R., and MEANS, E.D. (1988b). Pretreatment with alpha tocopherol enhances neurologic recovery after experimental spinal cord compression injury, J. Neurotrauma 5, 61-67.
3. BEHRMANN, D.L., BRESNAHAN, J.C., and BEATTIE, M.S. (1993). A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat. Exp. Neurol. 119, 258-267.
4. BEHRMANN, D.L., BRESNAHAN, J.C. and BEATTIE, M.S. (1994). Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp. Neurol. 126, 61-75.
5. BLIGHT, A.R. (1991a). Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 103, 156-171.
6. BLIGHT, A.R. (1991b). Morphometric analysis of blood vessels in chronic experimental spinal cord injury: hypervascularity and recovery of function. J. Neurol. Sci. 106, 158-174.
7. BLIGHT, A.R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9, S83-S91.
8. BLIGHT, A.R. (1993). Remyelination, revascularization and recovery of function in experimental spinal cord injury, in Advances in Neurology, Vol. 59, Neural Injury and Regeneration. Seil, F.J. (ed.). Raven Press: New York, pp. 91-104.
9. BLIGHT, A.R. (1994). Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 60, 263-273.
10. BLIGHT, A.R., COHEN, T.I., SAITO, K., and HEYES, M.P. (1995). Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118, 735-752.
11. BLIGHT, A.R., SAITO, K., and HEYES, M.P. (1993). Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury. Brain. Res. 632, 314-316.
12. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. New Engl. J. Med. 322, 1405-1461.
13. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1992). Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. J. Neurosurg. 76, 23-31.
14. BRESNAHAN, J.C., BEATTIE, M.S., and SHAH, B.R. (1992). Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis. J. Neurotrauma 9, 197-218.
15. BRESNAHAN, J.C., BEATTIE, M.S., TODD, F., and NOYES, D.H. (1987). A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95, 548-570.
16. COHEN, T.I., WEINBERG, R.J., and BLIGHT, A.R. (1996). Intrathecal infusion of the nitric oxide synathase inhibitor N-methyl-L-arginine after experimental spinal cord injury in guinea pigs. J. Neurotrauma 13, 361-369.
17. COOPER, G., and SCHILLER, A.L. (1975). Anatomy of the Guinea Pig. Harvard University Press: Cambridge, MA.
18. FADEN, A.L, ELLISON, J.A., and NOBLE, L.J. (1990). Effects of competitive and noncompetitive NMDA receptor antagonists in spinal cord injury. Europ. J. Pharmacol. 175, 165-174.
19. FADEN, A.I., JACOBS, T.P., and HOLADAY, J.W. (1981a). Opiate antagonist improves neurologic recovery after spinal injury. Science 211, 493-494.
20. FADEN, A.I., JACOBS, T.P., and HOLADAY, J.W. (1981b). Thyrotropin releasing hormone improves neurologic recovery after spinal trauma in cats. New Engl. J. Med. 305, 1063-1067.
21. FLAMM, E.S., YOUNG, W., DEMOPOULOS, H.B., DECRESCITO, V. and TOMASULA, J.J. (1982). Experimental spinal cord injury: treatment with naloxone. Neurosurgery 10, 227-231.
22. GALE, K., KERASIDIS, H., and WRATHALL, J. (1985). Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp. Neurol. 88, 123-134.
23. GIULIAN, D., VACA, K., and CORPUZ, M. (1993). Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
24. GRUNER, J.A., YEE, A.K., and BLIGHT, A.R. (1996). Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res. 729, 90-101.
25. HEBEL, R., and STROMBERG, M.W. (1976). Anatomy of the Laboratory Rat. Williams and Wilkins: Baltimore, MD.
26. HEYES, M.P., ACHIM, C., WILEY, C.A., MAJOR, E.O., CHEN, C.Y., SAITO, K., and MARKEY, S.P. (1996). Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochemical J. 320, 595-597.
27. 18O]-quinolinic acid: Its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed. Environ. Mass. Spectrom. 15, 291-293.
28. HEYES, M.P., and MARKEY, S.P. (1988b). Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: Effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal. Biochem. 174, 349-359.
29. HEYES, M.P., and MORRISON, P.F. (1997). Quantitation of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68, 280-288.
30. HEYES, M.P., SAITO, K., CROWLEY, J.S., et al. (1992a). Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 1249-1273.
31. HEYES, M.P., SAITO, K., and MARKEY, S.P. (1992b). Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283, 633-635.
32. HEYES, M.P., SAITO, K., MAJOR, E.O., MILSTIEN, S., MARKEY, S.P., and VICKERS, J.H. (1993). A mechanism of quinolinic acid formation by the brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116, 1425-1450.
33. JAEGER, C.B., MCGRIFF, A.M., and BLIGHT, A.R. (1995). Structure of leaky and repaired blood-brain barrier endothelium after compression injury in guinea pig spinal cord. J. Neurotrauma 12, 453.
34. NOBLE, L.J., and WRATHALL, J.R. (1989a). Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp. Neurol. 103, 34-40.
35. NOBLE, L.J., and WRATHALL, J.R. (1989b). Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 482, 57-66.
36. POPOVICH, P.G., REINHARD, J., JR., FLANAGAN, E.M., and STOKES, B.T. (1994). Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res. 633, 348-352.
37. RIVLIN, A., and TATOR, C. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
38. SOMERSON, S.K. and STOKES, B.T. (1987). Functional analysis of an electromechanical spinal cord injury device. Exp. Neurol. 96, 82-96.
39. THOMAS, S.R., MOHR, D., and STOCKER, R. (1994). Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J. Biol. Chem. 269, 14457-14464.
40. WRATHALL, J.R., CHOINIERE, D., and TENG, Y.D. (1994). Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14, 6598-6607.
41. YOUNG, W., DECRESCITO, V., FLAMM, E.S., BLIGHT, A.R., and GRUNER, J.A. (1988). Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clin. Neurosurg. 34, 675-697.